To assess the efficacy of dexmedetomidine and levobupivacaine in tap block for Post operative pai

Phase 4

• Conditions: Health Condition 1: O- Medical and Surgical

• Registration Number: CTRI/2023/07/055537
• Lead Sponsor: Career institute of medical science and hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

ASA grade I/II belonging to American Society of Anaesthesiologists (ASA)

Age group 18 to 65 years

Patient undergoing abdominal surgeries under general anesthesia/spinal anesthesia will enrolled in the study

Patient willing to give consent

Exclusion Criteria

Patients with history of :

Allergy to LEVOBUPIVACAINE

Body mass index >35 kg.mâ??2

Preoperative opioid or nonsteroidal anti-inflammatory drug treatment for chronic pain.

Morbid obesity

Cardiac disorders - ischaemic heart disease, hypertension

Renal dysfunction - chronic renal failure,acute kidney disease.

Pre-existing neurological deficits,psychiatric illness will be excluded from the study.

If the laparoscopic surgery will be switched to open procedure, the patient will be excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Onset & duration of Sensory blockade <br/ ><br>Duration of post operative analgesia <br/ ><br>Visual analogue scoreTimepoint: 18 months

Secondary Outcome Measures

Name	Time	Method
Postoperative rescue analgesic requirement <br/ ><br>Side effects or complicationsTimepoint: 18 months